Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2024Nephrology Dialysis TransplantationOpen Access

#1614 Fenofibrates and chronic kidney disease – Is there anything to worry about?

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaria Beatriz BessaSSSónia SousaCMCarla Moreira

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bessa et al. (2024) studied this question.

synapsesocial.com/papers/68e6c836b6db643587646bdehttps://doi.org/10.1093/ndt/gfae069.1374
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study2024 · 6 citations
  2. 2Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes2009 · 82 citations
  3. 3Fenofibrate-associated rhabdomyolysis complicated by dialysis-requiring acute kidney injury presenting with atypical clinical manifestations2026
  4. 4Effect of Short-term Fenofibrate Therapy on Blood Creatinine Levels in Patients with Hypertriglyceridemia2014 · 1 citations
  5. 5New Fibrate Use and Acute Renal Outcomes in Elderly Adults2012 · 258 citations